Category: Training

Collaboration is the foundation needed to develop Scotland’s future Life Sciences skill set

Last year, Scotland’s National Strategy for Economic Transformation (NSET) identified both the bioeconomy and life sciences as sectors of major opportunity.

Speaking on 29 November, at The Scotsman’s Life Science conference, Dr Claire Garden* officially launched the report from the recent Life and Chemical Sciences Skills Summit.

“This sector is so effective in driving economic growth, and so important for the future prosperity of our country,” Dr Garden told the audience.

The sector can also play a major role in achieving the Scottish Government’s ambitions for fair and green economic growth.

“The Life and Chemical Sciences sector employs about 1.1% of the Scottish workforce but contributes 4.4% of Scotland’s total economy (GVA),” added Dr Garden. “The sector is also on track to increase its contribution to the Scottish economy to a total of £8bn by 2025, and Scotland’s Life Sciences sector is world-leading, partly because of its highly skilled and internationally recognised workforce.”

But what skills will be needed in future?

The first Life and Chemical Sciences Skills Summit was successfully led and hosted by Dr Garden in September 2023, with support from SULSA (Scottish Universities Life Sciences Alliance) and Skills Development Scotland.

“We brought together 80 representatives from industry, tertiary education, skills providers, and other key stakeholders, to collectively address two priority areas: the work-readiness of new entrants, and collaborative working between industry and tertiary education.”

Themes of consolidation, collaboration and challenge emerged, and discussions identified 15 recommendations that could all be grouped under two clear needs:

  • A centralised umbrella skills organisation for Life Sciences.
  • A sector skills platform for Scotland – comprising both physical and digital spaces to bring together and signpost all skills assets.

“Together, the organisation and platform would facilitate the kind of collaborative, creative work that we know will be required to meet the challenges set out by The Entrepreneurial Campus, Green Skills, and Digital and Data challenges set by government.”

The sector’s vision

There are two key strategies that set the vision for the sector’s future. First, the Life Sciences Strategy for Scotland 2025, which aims to make Scotland the location of choice for Life Sciences businesses, researchers, healthcare professionals and investors, while increasing Life Sciences contribution to Scotland’s economic growth.

The second is The National Plan for Industrial Biotechnology. It states that Scotland will become the go-to destination to incubate and grow bioeconomy businesses to scale; and to manufacture products and services desired by consumers and end-users that will facilitate the nation’s net zero 2045 ambition.

At the centre of both are the people and skills working in the sector.

“We know we need a skilled workforce, but the question of ‘which skills’ can be challenging,” said Dr Garden. “Businesses are telling us that the sector increasingly needs people to have multidisciplinary skills that combine scientific and non-scientific skill sets, such as: meta skills; digital and data; automation, AI and robotics; quality control and regulatory; green skills; commercial skills; and entrepreneurship.”

“At Edinburgh Napier, we are focussing now on consolidating our entrepreneurial offer to students, business, and our community: for example, through a Women’s Enterprise Hub; collaboration with businesses to incorporate more innovation challenge-based opportunities for our students; and an educator’s toolkit.

“We were delighted when the University was recently placed second in Scotland in the Entrepreneurial Impact Ranking, presented in the ‘Gateways to Growth Report’ by Octopus Ventures.

Closing with a call to action to all stakeholders across the sector, Dr Garden said: “It’s time now to consolidate and openly share our skills assets, and we must find smarter and more creative ways to continue to collaborate if we are to meet the challenges we face.”

* Dr Claire Garden is Associate Professor of Life Science Education and Head of Learning and Teaching in the School of Applied Sciences at Edinburgh Napier University.

LINKS

report from the recent Life and Chemical Sciences Skills Summit

digital-economy-skills-action-plan.pdf (skillsdevelopmentscotland.co.uk)

green-jobs-in-scotland-report_final-4.pdf (skillsdevelopmentscotland.co.uk)

 

Addressing Scotland’s skills gap in Advanced Therapies with a second upskilling course this May

After identifying a shortage of skills in advanced therapy and vaccine manufacturing in Scotland, Edinburgh Napier’s School of Applied Sciences teamed up with Charles Rover Laboratories last January and ran a short course for students and recent graduates interested in the topic.

The five-day programme – which formed part of the UK’s Advanced Therapies Skills Training Network (ATSTN) – was highly successful, with three of the graduates already being offered full-time employment in the Lifesciences industry. And the good news, the course is returning this May to train another cohort of interested participants.

Dr Claire Garden, Associate Professor in the School of Applied Sciences, says: “Advanced Therapies offer enormous potential and promise to protect our society from current and future diseases, but when the UK government conducted research with companies in 2019, 83% were concerned about their ability to capitalise on emerging opportunities because skills anticipated to be essential were – at that time – missing. With our industry skills focus and partnership with key employers, recognised in our recent reaccreditation by the Royal Society of Biology, we have the track record to continue bringing this training to a wide audience.”

On the course, students learn about Good Laboratory Practice and are supplied with theoretical knowledge, including sterile manufacturing and the development and production of Advanced Therapies. In addition, they gain practical skills that allow for entering the Advanced Therapies workforce, such as cell culture and immunoassay techniques, and lab auditing; and learn about the quality and regulatory environment as well as the Good Manufacturing Practice within an industrial setting.

Carmen Martel – a student from the first cohort shared her experiences with us, stating, “Through the ATSTN advanced therapies course I got to experience how an industry laboratory operates and it helped me decide whether that was the industry I wanted to work in. It also put me in contact with valuable people in the field and helped me secure a job even before graduating.”

Another student, Petra Ceresnikova told us, “Having the opportunity to participate in the ATSTN course allowed me to act more confidently in the skills that I build over the years of studies. The environment of the course, the experience of the industrial work, and the very welcoming and supportive staff inspired me to try and apply for a job at Charles River laboratories. Before, I would hesitate, however, this course gave me an inside into what the job would be, together with skills needed and increased confidence in my technical performance.”

ATSTN was launched in 2020 and operates through three centres, two in England and one in Scotland. Edinburgh Napier is the only university in Scotland to be a member of ATSTN. This week, the School of Applied Sciences will partner once again with RoslinCT, SULSA (the Scottish Universities Life Sciences Alliance), the Industrial Biotechnology Innovation Centre, and Ayrshire College to deliver this bespoke and highly targeted training programme.

Helping Elite Athletes Become Entrepreneurs

The Athletes as Entrepreneurs (AtLAS) training programme is a fantastic opportunity for high-level athletes who want to learn about starting a business in just five weeks. And it’s free!

The online course taught via MOOC starts on the 17th of January and will finish on the 20th of February. Attendees will learn about entrepreneurship through five modules and be supported by business experts and athlete entrepreneurs who will act as mentors. ENU lecturer, Dr Tom Campbell expressed his enthusiasm about the programme: “We are very excited to be able to offer this innovative new course to elite athletes considering a future in entrepreneurship. The training programme will be delivered in collaboration with experts from across Europe and is underpinned by research led by the team here at ENU”.

AtLAS is a flexible and hands-on course that is tailored to the specific needs of elite athletes with the single aim of upgrading their entrepreneurial skills, enabling them to develop viable business ideas. According to Dr Susan Brown from the School of Applied Sciences, the programme gives sportspeople the chance to acquire the competencies necessary for a business career: “The course provides an excellent opportunity for students to develop skills for the future while simultaneously building an entrepreneurial network”.

The programme is open to all athletes who are current or former national or international level competitors. Click here for more information and to sign up for the course.

The five modules will cover theory and practice in the following areas: the entrepreneurial individual, basic skills for entrepreneurship, entrepreneurial thinking & mindset, entrepreneurial process, founding a company. Upon completion, participants will receive an AtLAS training certificate that is worth 1 ECTS credit.

School joins new UK Advanced Therapies Skills Training Network

A new national training centre in Scotland is to help drive development of opportunities emerging in vaccine manufacturing, as well as cell and gene therapy.

It is one of new three UK training centres that together form The Advanced Therapies Skills Training Network (ATSTN).

All partners in the Network will now work collaboratively to address a skills gap first identified two years ago. In 2019, The Skills Demand Survey conducted by the UK government’s Cell and Gene Therapy (CGT) Catapult found rising concern among vaccine manufacturers and Advanced Therapy Medicinal Products (ATMP) companies about their ability to recruit and retain skilled talent in the UK.

In fact, 83% of companies were concerned about their ability to capitalise on emerging opportunities, because skills anticipated to be essential were – at that time – missing.

Created as a direct response, ATSTN is being backed by £4.7m from the Department for Business, Energy & Industrial Strategy (BEIS) and Innovate UK (IUK). Activity across all the UK partners will be coordinated by the CGT Catapult.

In Scotland, the Network’s delivery is being led by RoslinCT –  a cell and gene therapy/ATMP Contract Development and Manufacturing Organization (CDMO) – via the RoslinCT Training Academy and The School of Applied Sciences at Edinburgh Napier University. Other delivery partners are North Ayrshire College, IBioIC, Skills Development Scotland, Scottish Universities Life Science Alliance and Scottish Enterprise.

“The ATSTN is a truly collaborative initiative, developed by industry in partnership with academia, and the expertise from all three centres will create a wealth of learning resources,” said Professor Gary Hutchison, Dean of the School of Applied Sciences. “Development and delivery of our own courses for the National Training Centre is testament to the work we have been doing here at Edinburgh Napier over the last decade; delivering graduates who are work-ready and have the expertise and skills to enable the therapies of the future, including new vaccines.”

Professor Gary Hutchison.

The Training Centre now aims to have its first ‘blended-learning’ courses available for delivery in Scotland by the end of 2021. Face-to-face content will be delivered at RoslinCT’s Edinburgh campus at their newly built state of the art facility.,

“We are delighted to lead the Scottish training centre,” said Janet Downie, Chief Executive at RoslinCT. “With the tremendous growth opportunities in both ATMP and vaccine manufacturing, we are all looking forward to working with The National Horizons Centre and the University of Birmingham  to deliver this UK-wide training service.”

With their complementary capabilities and vast wealth of experience across GMP/GxP, manufacturing and bioprocessing, all three centres will deliver a range of specialist courses to upskill industry professionals. Further information can be obtained by contacting Nathan Barnett, Project Co-ordinator, Advanced Therapies Skills Training Network (ATSTN).

ENDS